{"transactions":[{"id":1357112,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":85861,"kind":"person","name":"Davis Andrew","position":1,"cik":"0001932525","reported_name":"Davis Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2024-11-20T21:05:04.000Z","date":"2024-11-18","kind":"sale","planned":false,"acquired":false,"shares":5360,"price":4.08,"value":21868.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person acquired 2,014 shares of Class A Common Stock under the issuer's employee stock purchase plan on June 30, 2024."}],"balance_after":284685,"source":{"system":"sec-edgar","filing":"0000950170-24-129228","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024129228/ownership.xml","form_type":"4"}},{"id":1505338,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":85861,"kind":"person","name":"Davis Andrew","position":1,"cik":"0001932525","reported_name":"Davis Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2024-05-22T20:05:19.000Z","date":"2024-05-20","kind":"sale","planned":false,"acquired":false,"shares":22725,"price":6.45,"value":146576.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units and performance-based restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":288031,"source":{"system":"sec-edgar","filing":"0000950170-24-063482","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024063482/ownership.xml","form_type":"4"}},{"id":1580936,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":85861,"kind":"person","name":"Davis Andrew","position":1,"cik":"0001932525","reported_name":"Davis Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Performance-based Restricted Stock Unit","published_at":"2024-03-12T20:05:10.000Z","date":"2024-03-08","kind":"exercise","planned":false,"acquired":false,"shares":37120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs are earned upon the Issuer's Class A Common Stock achieving a specified price per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each PSU represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs are earned upon the Issuer's Class A Common Stock achieving a specified price per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Additional PSUs may vest upon the Issuer's Class A Common Stock achieving specified prices per share beyond the previously achieved vesting targets."}],"balance_after":0,"derivative":{"expiration_date":"2026-02-28","underlying":"Class A Common Stock","underlying_shares":37120},"source":{"system":"sec-edgar","filing":"0000950170-24-029910","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024029910/ownership.xml","form_type":"4"}},{"id":1580935,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":85861,"kind":"person","name":"Davis Andrew","position":1,"cik":"0001932525","reported_name":"Davis Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-12T20:05:10.000Z","date":"2024-03-08","kind":"exercise","planned":false,"acquired":true,"shares":37120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted on March 8, 2023. The earned PSUs were certified on February 12, 2024, and March 7, 2024, and vested on March 8, 2024."}],"balance_after":310756,"source":{"system":"sec-edgar","filing":"0000950170-24-029910","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024029910/ownership.xml","form_type":"4"}},{"id":1643047,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":85861,"kind":"person","name":"Davis Andrew","position":1,"cik":"0001932525","reported_name":"Davis Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Performance-based Restricted Stock Unit","published_at":"2024-02-15T01:42:46.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":32656,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share."}],"balance_after":32656,"derivative":{"expiration_date":"2027-02-28","underlying":"Class A Common Stock","underlying_shares":32656},"source":{"system":"sec-edgar","filing":"0000950170-24-015548","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024015548/ownership.xml","form_type":"4"}},{"id":1643046,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":85861,"kind":"person","name":"Davis Andrew","position":1,"cik":"0001932525","reported_name":"Davis Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-15T01:42:46.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":65312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":273636,"source":{"system":"sec-edgar","filing":"0000950170-24-015548","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024015548/ownership.xml","form_type":"4"}},{"id":1643045,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":85861,"kind":"person","name":"Davis Andrew","position":1,"cik":"0001932525","reported_name":"Davis Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-15T01:42:46.000Z","date":"2024-02-12","kind":"sale","planned":false,"acquired":false,"shares":9846,"price":15.24,"value":150053.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.85 to $15.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person acquired 796 shares of Class A Common Stock under the issuer's employee stock purchase plan on December 31, 2023."}],"balance_after":208324,"source":{"system":"sec-edgar","filing":"0000950170-24-015548","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024015548/ownership.xml","form_type":"4"}},{"id":1731097,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":85861,"kind":"person","name":"Davis Andrew","position":1,"cik":"0001932525","reported_name":"Davis Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-11-22T21:05:22.000Z","date":"2023-11-20","kind":"sale","planned":false,"acquired":false,"shares":3287,"price":9.69,"value":31851.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person acquired 1,334 shares of Class A common stock under the issuer's employee stock purchase plan on June 30, 2023."}],"balance_after":217374,"source":{"system":"sec-edgar","filing":"0001209191-23-056446","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919123056446/doc4.xml","form_type":"4"}},{"id":1879626,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":85861,"kind":"person","name":"Davis Andrew","position":1,"cik":"0001932525","reported_name":"Davis Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-05-24T20:05:41.000Z","date":"2023-05-22","kind":"sale","planned":false,"acquired":false,"shares":6305,"price":10.12,"value":63806.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":219327,"source":{"system":"sec-edgar","filing":"0001209191-23-031873","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919123031873/doc4.xml","form_type":"4"}},{"id":1958629,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":85861,"kind":"person","name":"Davis Andrew","position":1,"cik":"0001932525","reported_name":"Davis Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Performance-based Restricted Stock Units","published_at":"2023-03-10T22:07:07.000Z","date":"2023-03-08","kind":"grant","acquired":true,"shares":37118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share."}],"balance_after":37118,"derivative":{"expiration_date":"2026-02-28","underlying":"Class A Common Stock","underlying_shares":37118},"source":{"system":"sec-edgar","filing":"0001209191-23-017873","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919123017873/doc4.xml","form_type":"4"}},{"id":1958628,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":85861,"kind":"person","name":"Davis Andrew","position":1,"cik":"0001932525","reported_name":"Davis Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-10T22:07:07.000Z","date":"2023-03-08","kind":"grant","acquired":true,"shares":74236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":225632,"source":{"system":"sec-edgar","filing":"0001209191-23-017873","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919123017873/doc4.xml","form_type":"4"}},{"id":1983491,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":85861,"kind":"person","name":"Davis Andrew","position":1,"cik":"0001932525","reported_name":"Davis Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-01T23:17:09.000Z","date":"2023-02-28","kind":"sale","acquired":false,"shares":1822,"price":11.31,"value":20606.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.26 to $11.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":151396,"source":{"system":"sec-edgar","filing":"0001209191-23-014276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919123014276/doc4.xml","form_type":"4"}},{"id":1983490,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":85861,"kind":"person","name":"Davis Andrew","position":1,"cik":"0001932525","reported_name":"Davis Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-01T23:17:09.000Z","date":"2023-02-27","kind":"sale","acquired":false,"shares":1751,"price":11.41,"value":19978.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.29 to $11.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person acquired 756 shares of Class A Common Stock under the issuer's employee stock purchase plan on December 31, 2022."}],"balance_after":153218,"source":{"system":"sec-edgar","filing":"0001209191-23-014276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919123014276/doc4.xml","form_type":"4"}},{"id":2105149,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":85861,"kind":"person","name":"Davis Andrew","position":1,"cik":"0001932525","reported_name":"Davis Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2022-11-23T21:05:31.000Z","date":"2022-11-21","kind":"sale","acquired":false,"shares":3335,"price":11.56,"value":38552.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person acquired 1,032 shares of Class A Common Stock under the issuer's employee stock purchase plan on June 30, 2022."}],"balance_after":154213,"source":{"system":"sec-edgar","filing":"0001209191-22-058607","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919122058607/doc4.xml","form_type":"4"}}]}